Latest News for Sonoro Gold Stock (OTC:SMOFF)

Sonoro Gold Corp is an exploration and development company holding the near development stage Cerro Caliche project and the exploration stage San Marcial properties in Sonora State, Mexico. The company has one business segment, the exploration of mineral properties.

Sonoro Gold Corp

WIIM

CF Industries Holdings shares are trading lower. The company reported Q1 financial results.

Host Hotels & Resorts shares are trading lower. The company reported Q1 financial results.

BMO Capital analyst Andrew Strelzik maintains Wingstop (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WING#NASDAQ">WING</a>) with a Market Perform and raises the price target from $275 to $325.

News

Price Target

Analyst Ratings

WING

BMO Capital Maintains Market Perform on Wingstop, Raises Price Target to $325

Macro Economic Events

Econ #s

Economics

USA Natural Gas Storage 59B Vs 68B Est.; 92B Prior

Regeneron Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>) has outperformed the market over the past 20 years by 15.96% on an annualized basis producing an average annual return of 23.84%. Currently, Regeneron Pharmaceuticals has a market capitalization of $100.69 billion. 
Buying $100 In REGN: If an investor had bought $100 of REGN stock 20 years ago, it would be worth $7,527.35 today based on a price of $913.82 for REGN at the time of writing.
<h3>Regeneron Pharmaceuticals's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714660219_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

REGN

Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 20 Years

Cigna Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CI#NYSE">CI</a>) has outperformed the market over the past 15 years by 7.82% on an annualized basis producing an average annual return of 19.7%. Currently, Cigna Group has a market capitalization of $99.68 billion. 
Buying $1000 In CI: If an investor had bought $1000 of CI stock 15 years ago, it would be worth $15,729.86 today based on a price of $351.40 for CI at the time of writing.
<h3>Cigna Group's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714660214_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $1000 In This Stock 15 Years Ago, You Would Have $16,000 Today

Since March 2023, 625 commercial loans have been foreclosed on — a 117% increase over the previous year, according to real estate research and data analysis firm ATTOM.
It's another data point illustrating how deep the commercial real estate sector's problems go. It's also alarming because the volume of commercial debt that can still go bad is massive.&nbsp;&nbsp;
The implications for the economy are frightening to contemplate and each day, America's commercial real estate sector takes another step toward the abyss. Commercial real estate foreclosures have been climbing since hitting a low of 141 in May 2020. The 625 foreclosure figure is the second-highest since ATTOM started analyzing the data in 2014 when there were 889 foreclosures.&nbsp;
Don't Miss:
<ul>
<li>Investing in real estate just got a whole lot simpler. This <a href="https://www.benzinga.com/money/bezos-landlord-100-dollars">Jeff Bezos-backed startup will allow you to become a landlord</a> in just 10 minutes, and you only need $100.</li>
<li>Want To Grow Your Wealth Passively? Unlock Real Wealth with <a href="https://www.benzinga.com/money/cityfunds-yield">Cityfunds&#8217; Exclusive 8% Yield Fund</a>.</li>
</ul>
If commercial vacancies persist, it's likely the previous record will be broken. The average vacancy rate in commercial properties hit an all-time high of 19.8% in the first quarter, according to a Moody's Analytics report. That exceeds the previous record of 19.6% set in the fourth quarter of 2023.
A 20% vacancy rate for six consecutive months is catastrophic for the balance sheets of most commercial real estate developers or property owners, who depend on buildings being 95% occupied by long-term tenants that are locked into scheduled rent increases. If the 95% occupancy target isn't hit, the property is likely to lose money and the developer will be unable to service the debt secured by the property.
Anyone who has financed a home knows that foreclosure proceedings begin when mortgage payments stop. The process isn't any different for commercial properties. Although the full measure of the pain hasn't been felt yet, nearly $3 trillion in commercial loan debt will come due between now and 2027. In the past, developers could refinance their debt at borrower-friendly interest rates that don't exist today.
Trending:
<ul>
<li>Want to Create a Passive Income Stream? <a href="https://www.benzinga.com/real-estate/23/05/32554601/want-to-grow-your-wealth-passively-these-high-yield-real-estate-notes-might-be-your-holy-grail">These High-Yield Real Estate Notes Might Be Your Holy Grail</a></li>
</ul>
When developers took out the loans that are set to mature by 2027, many assumed they would be able to roll their debt over into another loan as they had in the past. But now, if they can refinance the debt, the interest rates will be between 6% and 7% — not the 2% or 3% their existing loan was for. And now, refinancing the debt is contingent on proving their assets aren't toxic.
Banks are unlikely to lend or refinance debt on assets with 20% vacancy rates. If developers can't get financing, they'll be foreclosed on. That almost guarantees that commercial asset foreclosures will match or exceed their record high of 889 in the next few years.
Regional banks' exposure to commercial loans is causing concerns for many economic analysts and observers. Some estimate the coming foreclosure crisis could be worse than 2008, while others think it will not reach that extent.&nbsp; A better question might be how to turn America's millions of square feet of vacant commercial real estate from a toxic asset back into an economically viable investment.
&nbsp;Read Next:
<ul>
<li>Dara Khosrowshahi-Backed Startup Lets You <a href="https://www.benzinga.com/money/dara-khosrowshahi-backed-startup-lets-you-become-a-landlord-with-100">Become a Landlord with $100</a>.</li>
<li>Miami Is Expected To Take New York's Place As The US Financial Capital. <a href="https://www.benzinga.com/money/miami-take-new-yorks-place-financial-capital">Invest In It With $500 Before That Happens</a>.&nbsp;</li>
</ul>

Real Estate

Commercial Foreclosures Spike By Nearly 120% In The Last 12 Months

BMO Capital analyst James Thalacker maintains WEC Energy Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WEC#NYSE">WEC</a>) with a Market Perform and raises the price target from $89 to $90.

BMO Capital Maintains Market Perform on WEC Energy Group, Raises Price Target to $90

AMETEK shares are trading lower after the company reported worse-than-expected Q1 sales results.

BMO Capital analyst Jeffrey Silber maintains Verisk Analytics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRSK#NASDAQ">VRSK</a>) with a Market Perform and raises the price target from $238 to $241.

VRSK

BMO Capital Maintains Market Perform on Verisk Analytics, Raises Price Target to $241

RBC Capital analyst Brad Erickson maintains Carvana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) with a Sector Perform and raises the price target from $90 to $130.

CVNA

RBC Capital Maintains Sector Perform on Carvana, Raises Price Target to $130

GFL Environmental shares are trading higher after the company reported better-than-expected Q1 sales results and increased its FY24 guidance.

U.S. stocks were higher, with the Dow Jones index gaining over 50 points on Thursday.
Shares of C.H. Robinson Worldwide, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHRW#NASDAQ">CHRW</a>) rose sharply during Thursday's session after the company reported better-than-expected <a href="https://www.benzinga.com/quote/CHRW/earnings">first-quarter financial results</a>.
C.H. Robinson Worldwide posted adjusted earnings of 86 cents per share, beating market estimates of 82 cents per share. The company's quarterly sales came in at $4.412 billion versus expectations of $4.269 billion, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
C.H. Robinson Worldwide shares jumped 16.8% to $84.24 on Thursday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Aspen Aerogels, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASPN#NYSE">ASPN</a>) jumped 37.5% to $20.92 after the company reported better-than-expected first-quarter financial results.</li>
<li>Carvana Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) rose 35.8% to $118.19 after the company announced upbeat quarterly results.</li>
<li>Enovix Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENVX#NASDAQ">ENVX</a>) surged 27.1% to $8.27 after the company reported mixed first-quarter financial results.</li>
<li>Gannett Co., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GCI#NYSE">GCI</a>) rose 22.3% to $2.9519 following strong quarterly results.</li>
<li>Perdoceo Education Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRDO#NASDAQ">PRDO</a>) jumped 19.4% to $21.89 following upbeat results.</li>
<li>Pulmonx Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNG#NASDAQ">LUNG</a>) rose 19.2% to $9.20 after the company reported better-than-expected first-quarter financial results.</li>
<li>Benchmark Electronics, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHE#NYSE">BHE</a>) surged 18.3% to $35.82 following better-than-expected quarterly results.</li>
<li>Pitney Bowes Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBI#NYSE">PBI</a>) rose 18% to $4.97 following strong quarterly results.</li>
<li>Rush Street Interactive, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RSI#NYSE">RSI</a>) shares gained 17.4% to $7.53 after the company reported better-than-expected first-quarter financial results and issued FY24 revenue guidance above estimates.</li>
<li>Avis Budget Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAR#NASDAQ">CAR</a>) rose 15.7% to $109.62 after the company reported mixed first-quarter financial results.</li>
<li>Howmet Aerospace Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HWM#NYSE">HWM</a>) climbed 15.2% to $76.93 after the company reported better-than-expected first-quarter financial results.</li>
<li>Sunnova Energy International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOVA#NYSE">NOVA</a>) rose 15% to $4.0399 after the company reported better-than-expected first-quarter adjusted EPS results.</li>
<li>Valmont Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VMI#NYSE">VMI</a>) rose 14.4% to $237.65 after the company posted upbeat quarterly earnings and raised FY24 EPS guidance.</li>
<li>Blueprint Medicines Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPMC#NASDAQ">BPMC</a>) gained 13.7% to $107.81 after the company reported better-than-expected first-quarter results and raised FY24 revenue guidance.</li>
<li>Lantheus Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNTH#NASDAQ">LNTH</a>) surged 12.8% to $76.09 after the company reported better-than-expected first-quarter results and raised its FY24 adjusted EPS outlook.</li>
<li>Sprouts Farmers Market, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>) climbed 12% to $72.08 after the company reported better-than-expected first-quarter EPS and sales.</li>
<li>Wayfair Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/W#NYSE">W</a>) gained 11.7% to $56.53 after the company reported better-than-expected first-quarter financial results.</li>
<li>Tronox Holdings plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TROX#NYSE">TROX</a>) rose 10.8% to $18.94 following strong sales.</li>
<li>Kontoor Brands, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KTB#NYSE">KTB</a>) gained 9.9% to $68.29 following better-than-expected quarterly results.</li>
<li>QUALCOMM Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) climbed 8.5% to $178.02 after the company reported better-than-expected second-quarter financial results, raised its dividend and issued third-quarter guidance.</li>
<li>Belden Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BDC#NYSE">BDC</a>) gained 8.2% to $87.95 after the company reported mixed first-quarter earnings and announced the acquisition of Precision Optical Technologies.</li>
<li>Kellanova (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/K#NYSE">K</a>) rose 8.1% to $61.60 following upbeat earnings.</li>
<li>Glaukos Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GKOS#NYSE">GKOS</a>) gained 7.7% to $106.55 following strong sales.</li>
<li>Sealed Air Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SEE#NYSE">SEE</a>) surged 7.7% to $34.60 after the company reported better-than-expected quarterly financial results.</li>
<li>BorgWarner Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWA#NYSE">BWA</a>) gained 7.7% to $35.39 following upbeat earnings.</li>
<li>Itron, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITRI#NASDAQ">ITRI</a>) rose 7.4% to $98.39 following upbeat earnings.</li>
<li>IAC Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAC#NASDAQ">IAC</a>) gained 6.8% to $51.11 after it was announced the stock will join the S&amp;P SmallCap 600.</li>
<li>Moderna, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) shares jumped 6.5% to $118.75 following first-quarter results.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/05/38584879/apple-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call">Apple Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a>

Intraday Update

Markets

Movers

ASPN

BPMC

CHRW

ENVX

GKOS

ITRI

LNTH

LUNG

MRNA

NOVA

PRDO

QCOM

TROX

C.H. Robinson Worldwide Posts Upbeat Results, Joins Avis Budget Group, Qualcomm, BorgWarner, Moderna And Other Big Stocks Moving Higher On Thursday

BMO Capital analyst Kelly Bania maintains Sprouts Farmers Market (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>) with a Underperform and raises the price target from $31 to $40.

BMO Capital Maintains Underperform on Sprouts Farmers Market, Raises Price Target to $40

Despite a recent pause in inflows to spot bitcoin exchange-traded funds (ETFs) after <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38578855/bitcoin-spot-etfs-experience-record-564m-outflows-expert-attributes-it-to-combination-of-f">a continuous 71-day streak</a>, industry experts predict a resurgence led by a broader investor base. 
What Happened: Robert Mitchnick, head of digital assets at BlackRock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>), the world's leading asset management firm, suggests that the lull may soon be replaced by inflows from a variety of institutional investors.
According to Mitchnick, financial giants such as sovereign wealth funds, pension funds, and endowments are likely to begin engaging with spot ETFs in the upcoming months, Coindesk <a href="https://www.coindesk.com/business/2024/05/02/blackrock-sees-sovereign-wealth-funds-pensions-coming-to-bitcoin-etfs/">reported</a>. 
&#8220;The re-initiation of the discussion around bitcoin is turning on how to allocate BTC into portfolio constructions,&#8221; Mitchnick explained during an interview. 
He further elaborated on the educational role BlackRock has been playing to facilitate this transition: &#8220;Many of these interested firms are having ongoing diligence and research conversations, and we're playing a role from an education perspective.&#8221;
Since their approval in January, the pent-up demand for these ETFs has resulted in over $76 billion accumulated across various products. 
Mitchnick also highlighted that while some registered investment advisors (RIAs) are already offering BlackRock's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBIT#NASDAQ">IBIT</a>) ETF, a full-scale offering to clients of large wealth advisory firms like Morgan Stanley is anticipated soon.
Social media buzz often revolves around the comparison of assets under management between different funds such as IBIT and Grayscale's (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GBTC#OTC">GBTC</a>). 
At present, IBIT holds about $17.2 billion, trailing behind GBTC's $24.3 billion. 
However, a significant portion of IBIT's assets is attributed to transitions from Grayscale and inflows from higher priced international products or bitcoin futures ETFs converting into spot products.
Mitchnick pointed out that existing bitcoin holders prefer the ease of managing their cryptocurrency within a brokerage account, emphasizing the benefits over complexities like custody and tax reporting. 
&#8220;While becoming the biggest spot Bitcoin ETF would be an impressive milestone, BlackRock isn't really focused on that competition, but rather on educating its clients,&#8221; he stated.
Also Read:<a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38579045/jack-dorseys-block-under-examination-from-authorities-over-alleged-sanctions-violations"> Jack Dorsey&#8217;s Block Under Examination From Authorities Over Alleged Sanctions Violations</a>
Why It Matters: BlackRock has also been preparing the groundwork for an Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) ETF, with CEO Larry Fink discussing the potential of tokenization and the representation of traditional assets on blockchains last November. 
Mitchnick posed a critical question regarding investor education in the complex Ethereum ecosystem and the rationale for diversifying into another crypto ETF when a spot bitcoin ETF could already be enhancing portfolio Sharpe ratios.
Highlighting the broader potential, Mitchnick noted, &#8220;When we think about this space, we see the potential for digital assets to benefit our clients and capital markets, focusing on three areas: crypto assets, stablecoins and tokenization. These pillars are all interrelated, which is crucial for people to understand.&#8221;
What&#8217;s Next: As the digital asset landscape continues to evolve, discussions like these will be central at Benzinga&#8217;s upcoming <a href="https://www.benzinga.com/events/digital-assets/agenda/">Future of Digital Assets</a> event on Nov. 19, where industry leaders will converge to share insights and strategies for navigating the expanding world of digital finance.
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$ETH

GBTC

IBIT

BlackRock Anticipates Renewed Institutional Interest In Bitcoin Spot ETFs

RBC Capital analyst Brad Erickson maintains DoorDash (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DASH#NASDAQ">DASH</a>) with a Outperform and lowers the price target from $175 to $165.

DASH

RBC Capital Maintains Outperform on DoorDash, Lowers Price Target to $165

Moderna shares are trading higher after the company reported better-than-expected Q1 financial results.

Appian Corp&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APPN#NASDAQ">APPN</a>)&nbsp;reported fiscal first-quarter 2024 revenue growth of 11% year-on-year to $149.84 million, marginally beating the&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/05/g38577668/appian-announces-first-quarter-2024-financial-results" rel="noreferrer noopener">analyst consensus of $149.76 million</a>.
Adjusted&nbsp;EPS loss of 24 cents missed the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">analyst consensus loss of 16 cents</a>.&nbsp;The&nbsp;stock price plunged close to 20%&nbsp;after the results.
Total subscription revenue increased 19% year over year to $117.7 million.&nbsp;Professional services revenue was $32.1 million, down 11% year over year.
Outlook:&nbsp;Appian expects second-quarter revenue of $140.00 million&nbsp;&#8211; $144.00&nbsp;million, up by 10%&nbsp;&#8211;&nbsp;13% Y/Y against the&nbsp;consensus of $145.25 million. It projects an adjusted EPS loss of 34 cents to 28 cents versus the 0.29 cents consensus loss&nbsp;.
The&nbsp;<a target="_blank" href="https://www.benzinga.com/news/earnings/24/02/37162688/why-is-appian-corp-stock-shooting-upwards-thursday" rel="noreferrer noopener">company reiterated fiscal 2024</a>&nbsp;revenue of $615.00 million – $617.00 million, up by 13% Y/Y, below the consensus of $615.75 million. It projects adjusted EPS loss of $(0.85) &#8211; $(0.79) (prior $(0.73) – $(0.66)), against the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">consensus loss of $(0.68)</a>.
Appian&nbsp;stock gained over 1% in the last 12 months. Investors can gain exposure to the stock via&nbsp;First Trust Nasdaq Artificial Intelligence And Robotics ETF&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROBT#NASDAQ">ROBT</a>) and&nbsp;First Trust Cloud Computing ETF&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYY#NASDAQ">SKYY</a>).
Price Action: APPN shares traded lower by 20.10% at $29.35 on the last check Thursday.
Photo via Shutterstock

Earnings

Guidance

Tech

APPN

ROBT

SKYY

Cloud Computing Firm Appian Stock Nosedives After Q1 Print, What's Going On?

BMO Capital analyst Evan David Seigerman reiterates Pfizer (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>) with a Outperform and raises the price target from $33 to $36.

Reiteration

BMO Capital Reiterates Outperform on Pfizer, Raises Price Target to $36

Options

BABA

Alibaba Gr Holding Option Alert: Jun 21 $85 Calls at the Ask: 250 @ $2.0 vs 29723 OI; Earnings 5/14 Before Open Ref=$78.25

Sonoro Gold announces $3M private placemnet

Sonoro Gold announces C$1M private placement

Sonoro Gold announces revised $1M private placement

SMOFF

Press Releases

SONORO ANNOUNCES POSITIVE PEA RESULTS FOR CERRO CALICHE GOLD PROJECT: PRE-TAX NPV OF USD $71.4 MILLION AND PRE-TAX IRR OF 59%

SONORO GOLD ANNOUNCES CLOSING OF FINAL TRANCHE OF NON-BROKERED PRIVATE PLACEMENT

SONORO FILES PRELIMINARY ECONOMIC ASSESSMENT

Sonoro Gold looking to build "small operation with big returns" — analyst

SONORO GOLD ANNOUNCES $1 MILLION PRIVATE PLACEMENT

Sonoro Gold Corp announce raise as company look to accelerate drilling at Cerro Caliche

SONORO GOLD ANNOUNCES REVISED $1 MILLION PRIVATE PLACEMENT

SONORO GOLD ANNOUNCES CLOSING OF FIRST TRANCHE OF $1 MILLION NON-BROKERED PRIVATE PLACEMENT

SONORO GOLD APPOINTS KATHARINE REGAN TO BOARD OF DIRECTORS

SONORO GOLD CLOSES OVER-SUBSCRIBED $1 MILLION NON-BROKERED PRIVATE PLACEMENT

TSXV:SGO

Sonoro Gold

AACAF

AACAY

AAGIY

AAIGF

AAMMF

AAUKF

AAVMY

AAVVF

ABBRF

ABCP

ABILF

ABMC

ABNAF

ABSSF

ACDVF

ACGBY

ACHFF

ACKRF

ACNDF

ACNNF

ACOPF

ACRL

ACSAY

ACUIF

ADAD

ADDDF

ADDYY

ADMT

ADYEY

AEGOF

AERG

AETUF

AEXAY

AFLYY

AGCBF

AGESY

AGFAF

AGGFF

AHCHY

AHEXY

AHGIF

AHKSF

AHKSY

AHWSF

AIBGY

AIBRF

AIQUY

AIRRF

AISSF

AJMPF

AJXGF

AKAOQ

AKBTY

AKZOY

ALBY

ALEAF

ALFVY

ALIAF

ALIF

ALIZF

ALLVF

ALMTF

ALPMY

ALSMY

ALVOF

ALYI

AMADY

AMAZ

AMBBY

AMIGY

AMKAF

AMKBF

AMKBY

AMLZF

AMMX

AMRQQ

AMXEF

ANEWF

ANGPY

ANPDF

ANPDY

ANSLY

ANTH

ANXGF

ANZBY

ANZLY

AOIFF

AOMFF

AOTVF

APELY

APHD

APMCF

AQARF

ARAFF

ARESF

ARGKF

ARKAY

ARNGF

ARREF

ARRRF

Stocks That Hit 52-Week Highs On Tuesday

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Latest News for Sonoro Gold Stock (OTC:SMOFF)

Tuesday, March 24, 2020